Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORX:SS

97.0000 SEK 0.2500 0.26%

As of 11:30:00 ET on 05/22/2015.

Company Profile for Orexo AB (ORX)

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Contact Information

Orexo AB

Kungsgatan 109
Box 303
Uppsala, 751 05
Sweden
Phone: 46-18-780-88-00
Fax: 46-18-780-88-88

Key Executives for Orexo AB (ORX)

Nikolaj SoerensenPresident/CEOJesper LindChief Operating Officer
Peter EdmanChief Scientific OfficerMichael SumnerChief Medical Officer
Robert A DelucaPres:Orexo US INCHenrik JuuelExec VP/CFO
Beata AugenblickInvestor RelationsAesa HolmgrenHead:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil